[Efficacy of different antiphlogistic agents with respect to carrageenan-inflammation, compared with other models of inflammation].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000632:Aminopyrine / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002351:Carrageenan; D003911:Dextrans; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004195:Disease Models, Animal; D004487:Edema / Q000188:drug therapy*; D005439:Flufenamic Acid / Q000627:therapeutic use; D005557:Formaldehyde; D006099:Granuloma / Q000139:chemically induced; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy*; D007616:Kaolin; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D010047:Ovalbumin; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D051381:Rats; D012980:Sodium Salicylate / Q000627:therapeutic use; D014357:Trypsin
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D000632:Aminopyrine; D005557:Formaldehyde; D007616:Kaolin; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D002351:Carrageenan; D000324:Adrenocorticotropic Hormone; D010047:Ovalbumin; D011239:Prednisolone; D014357:Trypsin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D012980:Sodium Salicylate; D007213:Indomethacin; D004121:Dimethyl Sulfoxide
Zur Wirkungspotenz verschiedener Zir Wirkungspotenz verschiedener Antiphlogistika bei der 'carrageenin-entzündung' im Vergleich zu anderern Entzündungsmodellen.